EndeavorRx Testimonials
Gage, Gretchen, & Peter’s Story
Laurence & Kate’s Story
Jensen, Ami, & Mike’s Story
Featured families were actual users of EndeavorRx, compensated for their participation and feedback. Testimonials provided are voluntary and personal to the family featured.
EndeavorRx results and experiences may vary. See below for EndeavorRx Indications and Safety information.
“What impressed me the most about EndeavorRx when I first saw it was that collaboration between the video game, design, and neuroscience experts that is at the heart of EndeavorRx.”
– Amiad Fredman, MD
“EndeavorRx hones in on three specific elements: Focus, interference processing, and multitasking to strengthen attentional control.”
– Chris Dietrich PA-C, PSY-CAQ, DSc
“He had been playing EndeavorRx for probably a couple of weeks, and one of the first things his teacher said to us during our parent-teacher conference was, ‘I don’t know what’s changed over the last three weeks, but he’s like a different student academically.”
– Gretchen
Parent
“One of the things that really appealed to us about EndeavorRx was that it was a play based intervention. The Endeavor world is very creative, incredibly fun and colorful. Making it a fun way to do the work is important.”
– Kate
Parent
“He’s focusing on whatever he’s eating, doing his homework on his own, getting much more social, much better at communicating, and with his eye contact. And all of a sudden you realize – what’s changed? Well he’s been using EndeavorRx consistently.”
– Mike
Parent
Adam & Ash’s Story
Emily & Brittany’s Story
Kate, Kara & Trey’s Story
Featured families were actual users of EndeavorRx, compensated for their participation and feedback. Testimonials provided are voluntary and personal to the family featured.
EndeavorRx results and experiences may vary. See below for EndeavorRx Indications and Safety information.
EndeavorRx:
Indications, Safety and Cautions
Indications:
EndeavorRx is a digital therapeutic indicated to improve attention function as measured by computer-based testing in children ages 8-17 years old with primarily inattentive or combined-type ADHD, who have a demonstrated attention issue. Patients who engage with EndeavorRx demonstrate improvements in a digitally assessed measure, Test of Variables of Attention (TOVA®), of sustained and selective attention and may not display benefits in typical behavioral symptoms, such as hyperactivity. EndeavorRx should be considered for use as part of a therapeutic program that may include clinician-directed therapy, medication, and/or educational programs, which further address symptoms of the disorder.
Safety:
No serious adverse events were reported. Of 342 participants who received AKL-T01 in the two clinical trials supporting EndeavorRx authorization for age ranges 8-17, 17 participants (4.97%) experienced treatment-related adverse events (TE-ADE) (possible, probable, likely). TE-ADEs reported at greater than 1% across the studies include: frustration tolerance decreased (2.34%) and headache (1.17%). Other adverse events occurred less than 1% and included dizziness, emotional disorder, nausea, and aggression. All adverse events were transient and no events led to device discontinuation. Across other studies in children and adolescents with ADHD, rates of adverse events were similarly low (<10%) and no Serious Adverse Events have been reported. All reported adverse events across all clinical trials resolved at the end of treatment. Users should consider the totality of evidence presented along with their health care provider when considering incorporating AKL-T01 into their treatment plan.
Cautions:
Rx only: Federal law restricts this device to sale by or on the order of a licensed health care provider. EndeavorRx should only be used by the patient for whom the prescription was written. For medical questions, please contact your child’s healthcare provider. If you are experiencing a medical emergency, please dial 911. EndeavorRx is not intended to be used as a stand-alone therapeutic and is not a substitution for your child’s medication.
If your child experiences frustration, emotional reaction, dizziness, nausea, headache, eye-strain, or joint pain while playing EndeavorRx pause the treatment. If the problem persists contact your child’s healthcare provider. If your child experiences a seizure stop the treatment and contact your child’s healthcare provider.
EndeavorRx may not be appropriate for patients with photo-sensitive epilepsy, color blindness, or physical limitations that restrict use of a mobile device; parents should consult with their child’s healthcare provider.
Please follow all of your mobile device manufacturer’s instructions for the safe operation of your mobile device. For example, this may include appropriate volume settings, proper battery charging, not operating the device if damaged, and proper device disposal. Contact your mobile device manufacturer for any questions or concerns that pertain to your device.
